Symbol="CVAC"
AssetType="Common Stock"
Name="CureVac NV"
Description="CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany."
CIK="1809122"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="PAUL-EHRLICH-STRABE 15 TUBINGEN, BADEN-WURTTEMBERG, DE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1933633000"
EBITDA="-226372992"
PERatio="None"
PEGRatio="None"
BookValue="3.187"
DividendPerShare="0"
DividendYield="0"
EPS="-1.63"
RevenuePerShareTTM="0.257"
ProfitMargin="0"
OperatingMarginTTM="-4.781"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.42"
RevenueTTM="50176000"
GrossProfitTTM="-91549000"
DilutedEPSTTM="-1.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.708"
AnalystTargetPrice="16"
TrailingPE="-"
ForwardPE="9.17"
PriceToSalesRatioTTM="13.29"
PriceToBookRatio="2.071"
EVToRevenue="8.61"
EVToEBITDA="-8.89"
Beta="2.781"
num_52WeekHigh="14.19"
num_52WeekLow="5.63"
num_50DayMovingAverage="9.87"
num_200DayMovingAverage="8.53"
SharesOutstanding="223852000"
DividendDate="None"
ExDividendDate="None"
symbol="CVAC"
open="8.52"
high="9.02"
low="8.50"
price="8.79"
volume="378609.00"
latest_trading_day="2023-08-09"
previous_close="8.50"
change="0.29"
change_percent="3.4118%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="29"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="585240"
Change_recent_avg="0.01"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="174"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0002.jpeg"
image_negative_thumbnail_id_2="1112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="647"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_positive_thumbnail_id_2="986"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
